MJ
Therapeutic Areas
NanoViricides Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NV-387 | MPox / Smallpox | Phase II |
| NV-HHV-1 / HerpeCide | Shingles (VZV) - Topical | Phase I/II (implied) |
| HerpeCide Variants | HSV-1 (Cold Sores) | Preclinical |
| HIVCide | HIV / AIDS | Preclinical |
| Broad-Spectrum Candidates | Ebola/Marburg | Preclinical |